Factors affecting compliance in the use of prescription footwear in the management of diabetic foot disease by Bryan Watters
POSTER PRESENTATION Open Access
Factors affecting compliance in the use of
prescription footwear in the management of
diabetic foot disease
Bryan Watters
From Society of Chiropodists and Podiatrists Annual Conference 2010
Bournemouth, UK. 21-23 October 2010
Introduction
A poster presentation will be prepared to disseminate
the result of research conducted to investigate the
potential for the Health Belief Model as a tool to under-
stand the factors affecting compliance with the use of
prescribed footwear in diabetic foot disease.
Research design and methods
A self-completion postal questionnaire was developed
and applied in a South Wales Valley community to
investigate the health beliefs of 72 individuals provided
with prescription footwear for advanced diabetic foot
disease and to investigate the impact of these beliefs on
their compliance with prescription footwear.
Results
46.6% of respondents were found to be compliant with
their use of prescribed footwear at the 9.6 hours per day
threshold. Prior history of ulceration was found to be
associated with increased likelihood of compliance (j=
0.286, p= 0.031), which contests the finding of McFar-
lane & Jensen(2003). Recollection of advice to wear the
prescribed footwear indoors was also significantly asso-
ciated with compliance (j = - 0.486, p<0.01). Patients
who perceived prescribed footwear as beneficial used
them for a greater number of hours per day (r=0.286,
p =0.025). Patients who perceived diabetic foot ulcera-
tion as serious were more likely to perceive prescribed
footwear as beneficial (r=0.349, p=0.005) and patients
who perceived prescribed footwear as beneficial were
less likely to rate barriers to compliance as high (r=
-0.262, p=0.038). The correlation between the summary
health belief scale and reported daily hours of
prescription footwear was not significant (r=0.184,
p=0.163). An improved health belief model has been
constructed to enhance understanding of the factors
affecting compliance in this context.
It is recommended that the NHS provision of pre-
scription footwear should be focused toward patients
with a previous history of ulceration and those for
whom ulceration is imminent. Patients with pre-ulcera-
tive diabetic foot disease should be counseled to wear
protective commercial footwear indoors as well as when
walking outside.
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